HARVONI 12周用药方案(治疗中)
1)网名:Trish1 (初治、感染32年,8周治疗方案)
Age 51 年龄
Infected 1983 感染时间
GT 1a 分型
VL 5.1m 病毒量
Bx 2004 - Grd 1 Stg 1 肝损活检分级
Tx naive 初治
Started Harvoni 6/23/2015 (8 wks)(开始8周治疗时间)
4wk (during tx) - detected <15 (4周病毒量<15)
2)网名:nowhine (经治,12周 SVR3,注意: Q80K 阳性)
Gender: Male (男性)
Ht/Wt: 5'9 158 lbs. 58 years young (身高,体重,年龄)
GT(分型): 1A and Q80K positive, (il28b分型)CT
VL(初始病毒量): 7 mil
Previous Tx.(曾治疗情况和用药方案)
SOC INF/Rib Partial response Breakthrough (干扰素2联部分应答,病毒学突破)
Gilead Trail GS 9451 Protease, GS 5885 now ledipasvir, INF/Rib, Partial response Breakthrough
Started Harvoni on 3/24/15 (开始harvoni时间:15年3月24日)
4 week labs UNDETECTED, Liver funtion test all normal (4周未检测到,肝功全正常)
12 week labs about 3 weeks ago and STILL UNDETECTED (SVR3,治疗结束后3周病毒未检测到)
I have 12 more weeks and will post after next labs (将帖出12周检测结果(未更新))
3)网名:Sixfootfour (12周)
* Dx as Hep C early 2000(诊断时间)
* 分型:Geno 1b
* Stage 3-4 Fibrosis by Biopsy and FibroScan pre tx (肝纤3-4级)
* 初始病毒量:VL at start of TX > 6 mil
* ALT/AST High normal range at start of Tx
* 开始和结束时间 Started Harvoni 12 week course 3/6 - completion 5/29/2015
* Undetected at 7 weeks Tx 4/24/15
* ALT/AST Mid normal range at 7 week blood test
* Undetected at 10 weeks Tx 5/15/15
* Completed 12 weeks (84 pills) 6/28/15
* Waiting for SVR12(等待svr12检查数据)
4)网名:sabre (初治,12周)
Infected(感染)1980 / Diagnosed(确诊) 2008
分型:GT 1 / Treatment naive初治 /病毒量 VL 190,000
Biopsy活检 2008: stage 0 grade 1
Fibroscan肝弹 2015: F2 mild fibrosis
Chronic kidney disease (due to HCV) / Proteinuria
(HCV引起肾病,蛋白尿)
12 weeks Harvoni began on(12周harvoni治疗方案,开始时间) 03/28/2015
End of treatment(结束时间): 06/19/2015
Labs on 06/17/2015: Undetected 未检测到
5)网名:sisterbland (12周 经治)
1987/88 Contracted HCV 1a 感染时间及分型
1997 Interferon/ribavirin 7 mo; relapser二联7个月复发
3/17/15 Harvoni started, 12 wks(开始治疗时间)
4/17/15 VL <15 IU/ML (Undetected)
6/11/15 Complete tx
6)网名:KC (12周)
Age 58 年龄
DX early 90's (90年代初确诊)
2/16/15 VL: 3,577,985 初始病毒量
AST: 81 ALT: 94 肝功
Fibrosis: F1 - F2 肝纤分级
3/18/15: Began Harvoni (12 week treatment)(开始12周治疗时间)
4/16/15: VL "UNDETECTED" <15(4周病毒量<15)
ALT: 29 AST: 30(肝功正常)
7)网名:S.Belle (12周、初治,肝纤3级,治疗2周alt asl由100降至正常,病毒检测不到)
Genotype 1 分型
Infected in early (感染)1990's Diagnosed in (确诊)2008
No previous treatment 初治
Fibrosure score F3 肝纤分级
Viral Load 94,000 初始病毒量
ALT 117 AST 115 初始肝功
Started Harvoni on July 14, 2015 (12 weeks)(开始12周治疗日期:15年7月14日)
Two weeks into Harvoni blood test results:
ALT 13 AST 21
Viral Load = UNDETECTED !!!
(治疗2周肝功检查正常,病毒量未检测到)
8)网名:Bree (经治,12周)
Dx 1997 Geno 1a(确诊时间:1997,分型:1a)
2002-2003 PEG Intron/riba (for 48 wks) - relapsed
(2002-2003年,干扰素二联,复发)
Viral Load: 13M - Log 7.1(病毒量)
Current Fibrosure Score F1-2(肝纤分级:F1-F2)
Started Harvoni (12 weeks) on July 6, 2015
(harvoni(12周方案),开始时间2015年7月6日)